Surgery Partners Inc

Surgery Partners Inc(SGRY)股票分析

$14.170

+0.193 (+1.36%)收盤時

Loading chart…
High
14.370
Open
14.130
VWAP
14.14
Vol
1.63M
Mkt Cap
3.09B
Low
13.875
Amount
23.11M
EV/EBITDA, TTM
9.53

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.

AI analysis of Surgery Partners Inc (SGRY)

hold

Surgery Partners Inc is currently a hold. The stock is priced at $13.69, which is significantly below the analyst price targets of $18 and $19, indicating potential upside. However, the RSI is at 32.53, suggesting the stock is oversold, and the recent insider selling has increased by 258.25%, which raises concerns about management's confidence. The company is also facing a challenging financial environment with a year-to-date change of -10.29% and a one-year change of -39.37%.

Analyst Ratings (9)

+85.60% upside
Buy
4 Buy
4 Hold
1 Sell
Current: 14.17
最低
18.00
平均
26.30
最高
36.00

RBC Capital

2026-08-11

目標價

$19

Outperform

TD Cowen

2026-08-11

目標價

$19

Buy

Cantor Fitzgerald

2026-08-11

目標價

$18

Overweight

Jefferies

2026-05-06

目標價

$17

Buy

Jefferies

2026-04-20

目標價

$15

Buy

估值指標

The current forward P/E ratio for Surgery Partners Inc (SGRY) is 18.98, compared to its 5-year average forward P/E of -12.25.

Forward P/E

Fair
5Y Average P/E
-12.25
Current P/E
18.98
高估
753.14
低估
-777.63

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
15.98
Current EV/EBITDA
9.53
高估
20.26
低估
11.71

Forward P/S

Undervalued
5Y Average P/S
1.12
Current P/S
0.51
高估
1.52
低估
0.71

Alphio AI Price Scenarios for SGRY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SGRY

$22.84

情境價格

B

Base

Base · 50%SGRY

$21.90

情境價格

B

Bear

Bear · 25%SGRY

$21.04

情境價格

Whales holding SGRY

J

Jaunty Global Limited

+ HoldingSGRY

+0.64%

3M Return

P

Pentwater Capital Management LP

+ HoldingSGRY

-8.03%

3M Return

D

Davidson Kempner Capital Management LP

+ HoldingSGRY

-11.76%

3M Return

事件時間軸

2026-08-23 (ET)

00:00:00

Charter Communications Short Interest Rises to 32.4%

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

08:00:00

Company Reaffirms 2026 Revenue Outlook of $3.35B to $3.45B

08:00:00

Company Reports Q2 Revenue of $848.9M, Exceeds Expectations

資訊

SGRY FAQ — answered by Alphio AI

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Surgery Partners Inc is currently a hold. The stock is priced at $13.69, which is significantly below the analyst price targets of $18 and $19, indicating potential upside. However, the RSI is at 32.53, suggesting the stock is oversold, and the recent insider selling has increased by 258.25%, which raises concerns about management's confidence. The company is also facing a challenging financial environment with a year-to-date change of -10.29% and a one-year change of -39.37%.

9 analysts cover SGRY: 4 rate it Buy, 4 Hold and 1 Sell. The average price target is 26.30.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始